Med-tech companies raised a total of $1.7 billion in financings in June, a decrease of 21.64% compared to the same month last year. Volume of med-tech financings are also down: 30 in June 2023 compared to 41 in June 2022. Numbers are down significantly from the 56 financings worth $4.45 billion in June 2021, 76 financings worth $5.27 billion in June 2020, and 47 worth $2.08 billion in June 2019.
In the first five months of 2023, med-tech deal value is at the highest amount in recent years – up 128.219% from last year – while deal volume has decreased by 12.29%. Through May this year, 742 med-tech deals have raised a potential $5.38 billion, compared to 846 deals totalling $2.36 billion last year. The two recent years are vastly more than 2021, when through May there were 661 deals raising $386.69 million.
Med-tech companies raised $8.65 billion in the first five months of the year, a decrease of 34.9% from the $13.29 billion raised in the same time frame last year. The number of deals is down 33.04% from last year, from 230 to 154.
RSS
